{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["73(2)"],"submitter":["Ferrari A"],"pubmed_abstract":["<h4>Purpose</h4>The aim of this study was to evaluate the potential of hair analysis to monitor medication adherence in headache patients undergoing chronic therapy. For this purpose, the following parameters were analyzed: the detection rate of 23 therapeutic drugs in headache patients' hair, the degree of agreement between the self-reported drug and the drug found in hair, and whether the levels found in hair reflected the drug intake reported by the patients.<h4>Methods</h4>The study included 93 patients suffering from primary headaches declaring their daily intake of at least one of the following drugs during the 3 months before the hair sampling: alprazolam, amitriptyline, citalopram, clomipramine, clonazepam, delorazepam, diazepam, duloxetine, fluoxetine, flurazepam, levomepromazine,"],"journal":["European journal of clinical pharmacology"],"pagination":["197-203"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC5226977"],"repository":["biostudies-literature"],"pubmed_title":["Monitoring of adherence to headache treatments by means of hair analysis."],"pmcid":["PMC5226977"],"pubmed_authors":["Licata M","Vandelli D","Ferrari A","Baraldi C","Silingardi E","Verri P","Rustichelli C","Palazzoli F","Marchesi F"],"additional_accession":[]},"is_claimable":false,"name":"Monitoring of adherence to headache treatments by means of hair analysis.","description":"<h4>Purpose</h4>The aim of this study was to evaluate the potential of hair analysis to monitor medication adherence in headache patients undergoing chronic therapy. For this purpose, the following parameters were analyzed: the detection rate of 23 therapeutic drugs in headache patients' hair, the degree of agreement between the self-reported drug and the drug found in hair, and whether the levels found in hair reflected the drug intake reported by the patients.<h4>Methods</h4>The study included 93 patients suffering from primary headaches declaring their daily intake of at least one of the following drugs during the 3 months before the hair sampling: alprazolam, amitriptyline, citalopram, clomipramine, clonazepam, delorazepam, diazepam, duloxetine, fluoxetine, flurazepam, levomepromazine,","dates":{"release":"2017-01-01T00:00:00Z","publication":"2017 Feb","modification":"2025-06-01T03:23:09.939Z","creation":"2025-06-01T03:23:09.939Z"},"accession":"S-EPMC5226977","cross_references":{"pubmed":["27866243"],"doi":["10.1007/s00228-016-2163-5"]}}